28 results
425
EX-99.1
KA
Kineta Inc
24 Aug 20
Business combination disclosure
5:28pm
with PTI should enable the combined company to grow faster, deliver potential therapies to patients more quickly and create sustainable shareholder
8-K
EX-99.1
KA
Kineta Inc
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
with PTI should enable the combined company to grow faster, deliver potential therapies to patients more quickly and create sustainable shareholder
425
EX-99.3
KA
Kineta Inc
24 Aug 20
Business combination disclosure
5:28pm
a strong foundation for sustainable value creation illustrated by the potential for north of $600 million in future milestones plus royalties, including
8-K
EX-99.3
KA
Kineta Inc
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
a strong foundation for sustainable value creation illustrated by the potential for north of $600 million in future milestones plus royalties, including
8-K/A
EX-99.7
KA
Kineta Inc
3 Feb 21
Other Events
4:59pm
platform;
develops a sustainable and scalable manufacturing process for its product candidates, as well as establishes and maintains commercially
8-K/A
EX-99.2
w3ir6e
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.1
mwtzj
3 Feb 21
Other Events
4:59pm
8-K
EX-99.5
xyf0fkpp2 dg
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
8l20h68
10 Nov 22
Prospectus supplement
4:21pm